as 12-23-2024 4:00pm EST
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
Founded: | 2019 | Country: | United States |
Employees: | N/A | City: | MINNEAPOLIS |
Market Cap: | 8.0M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 8.9M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.07 | EPS Growth: | N/A |
52 Week Low/High: | $0.13 - $1.30 | Next Earning Date: | 11-19-2024 |
Revenue: | $1,341,000 | Revenue Growth: | 196.03% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
FOXO Breaking Stock News: Dive into FOXO Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 hours ago
GlobeNewswire
7 days ago
GlobeNewswire
13 days ago
GlobeNewswire
22 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
The information presented on this page, "FOXO FOXO Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.